Gladius Capital Management LP Pfizer Inc Transaction History

Gladius Capital Management LP

$99.2 Million
Q2 2024

A detailed history of Gladius Capital Management LP transactions in Pfizer Inc stock. As of the latest transaction made, Gladius Capital Management LP holds 36,628 shares of PFE stock, worth $1.04 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

36,628

Previous 5,122 615.11%

Holding current value

$1.04 Million

Previous $142,000 621.13%

% of portfolio

1.03%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $795,841 - $932,577	31,506 Added 615.11%	36,628 $1.02 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $91,003 - $104,500	3,515 Added 218.73%	5,122 $142,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $2.41 Million - $3.13 Million	-92,174 Reduced 98.29%	1,607 $46,000
Q3 2023 Dec 18, 2023	BUY	$32.09 - $37.51 $2.16 Million - $2.53 Million	67,349 Added 254.8%	93,781 $3.11 Million
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $2.16 Million - $2.53 Million	67,349 Added 254.8%	93,781 $3.11 Million
Q2 2023 Dec 18, 2023	SELL	$36.12 - $41.79 $2.43 Million - $2.81 Million	-67,349 Reduced 71.82%	26,432 $969,000
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $658,901 - $762,333	-18,242 Reduced 40.83%	26,432 $970,000
Q1 2023 Dec 18, 2023	SELL	$39.39 - $51.28 $1.93 Million - $2.52 Million	-49,107 Reduced 52.36%	44,674 $1.82 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $1.42 Million - $1.84 Million	35,972 Added 413.38%	44,674 $1.82 Million
Q4 2022 Dec 18, 2023	SELL	$41.75 - $54.5 $3.55 Million - $4.64 Million	-85,079 Reduced 90.72%	8,702 $446,000
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $2.59 Million - $3.38 Million	-61,936 Reduced 87.68%	8,702 $446,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $3.05 Million - $3.72 Million	69,663 Added 7144.92%	70,638 $3.09 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $301,142 - $357,060	-6,472 Reduced 86.91%	975 $52,000
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $21,777 - $26,984	476 Added 6.83%	7,447 $386,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $266,596 - $395,185	6,452 Added 1243.16%	6,971 $412,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $90,275 - $115,966	-2,300 Reduced 81.59%	519 $23,000
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $223,467 - $253,151	-6,223 Reduced 68.82%	2,819 $111,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $302,816 - $341,516	9,042 New	9,042 $328,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $170,328 - $216,587	-5,089 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $161,575 - $189,565	5,089 New	5,089 $187,000
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $940,049 - $1.34 Million	-34,778 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $1.14 Million - $1.3 Million	34,778 New	34,778 $1.36 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $242,375 - $314,289	-7,460 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $3.41 Million - $3.83 Million	-92,219 Reduced 92.52%	7,460 $327,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $2.57 Million - $2.82 Million	-68,536 Reduced 40.74%	99,679 $0
Q4 2018 Feb 15, 2019	BUY	$38.47 - $43.86 $6.22 Million - $7.1 Million	161,799 Added 2521.8%	168,215 $6.97 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $511,190 - $620,042	-14,830 Reduced 69.8%	6,416 $0
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $700,693 - $747,009	21,246 New	21,246 $771,000

Others Institutions Holding PFE

# of Institutions

3,233

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Account

Gladius Capital Management LP Pfizer Inc Transaction History